Skip to main content
Steve McWilliam

Dr Steve McWilliam
BA MBBS PhD MRCPCH

Publications

What type of publication do you want to show?

2024

2022

459 Nephrotoxin-associated AKI in non-critically ill children: A single centre prospective audit

Hankinson, C., Oni, L., Jorgensen, A., & McWilliam, S. (2022). 459 Nephrotoxin-associated AKI in non-critically ill children: A single centre prospective audit. In British Association for Community Child Health (pp. A92.3-A93). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2022-rcpch.150

DOI
10.1136/archdischild-2022-rcpch.150
Conference Paper

Nephrotoxic drugs and renal function in preterm infants: are urinary biomarkers the answer?

McWilliam, S. J., Turner, M. A., & Davis, J. M. (2022). Nephrotoxic drugs and renal function in preterm infants: are urinary biomarkers the answer?. PEDIATRIC RESEARCH, 92(1), 22-24. doi:10.1038/s41390-022-02049-0

DOI
10.1038/s41390-022-02049-0
Journal article

2021

2020

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Angus, D. C., Derde, L., Al-Beidh, F., Annane, D., Arabi, Y., Beane, A., . . . Summers, C. (2020). Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.. JAMA, 324(13), 1317-1329. doi:10.1001/jama.2020.17022

DOI
10.1001/jama.2020.17022
Journal article

G329(P) Incidence of amphotericin-induced acute kidney injury in a paediatric population: a systematic review

Mistry, D., Oni, L., & McWilliam, S. J. (2020). G329(P) Incidence of amphotericin-induced acute kidney injury in a paediatric population: a systematic review. In British association for paediatric nephrology (pp. A119.1-A119). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2020-rcpch.284

DOI
10.1136/archdischild-2020-rcpch.284
Conference Paper

G330(P) A systematic review of the risk factors associated with vancomycin-induced acute kidney injury in children

Williams, C., Oni, L., & McWilliam, S. J. (2020). G330(P) A systematic review of the risk factors associated with vancomycin-induced acute kidney injury in children. In British association for paediatric nephrology (pp. A119.2-A119). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2020-rcpch.285

DOI
10.1136/archdischild-2020-rcpch.285
Conference Paper

G334(P) Risk factors associated with ibuprofen induced acute kidney injury in the paediatric population: a systematic review

Cousins, S., Oni, L., & McWilliam, S. J. (2020). G334(P) Risk factors associated with ibuprofen induced acute kidney injury in the paediatric population: a systematic review. In British association for paediatric nephrology (pp. A121.1-A121). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2020-rcpch.288

DOI
10.1136/archdischild-2020-rcpch.288
Conference Paper

G344(P) Vancomycin-induced acute kidney injury in non-critically ill children at a tertiary paediatric hospital

Redding, D. E., & McWilliam, S. J. (2020). G344(P) Vancomycin-induced acute kidney injury in non-critically ill children at a tertiary paediatric hospital. In British association for paediatric nephrology (pp. A124.1-A124). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2020-rcpch.296

DOI
10.1136/archdischild-2020-rcpch.296
Conference Paper

A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.

McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., . . . Pirmohamed, M. (2020). A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.. Scientific reports, 10(1). doi:10.1038/s41598-020-58790-1

DOI
10.1038/s41598-020-58790-1
Journal article

2018

Solving the problem of dose optimisation of children’s medicines

McWilliam, S., & Hawcutt, D. B. (2018). Solving the problem of dose optimisation of children’s medicines. Expert Review of Clinical Pharmacology, 11(3), 205-208. doi:10.1080/17512433.2018.1431528

DOI
10.1080/17512433.2018.1431528
Journal article

2017

THE PROTEKT STUDY - A PHASE IIA, RANDOMISED, CONTROLLED, OPEN-LABEL TRIAL OF ROSUVASTATIN FOR THE PREVENTION OF AMINOGLYCOSIDE-INDUCED KIDNEY TOXICITY IN CHILDREN WITH CYSTIC FIBROSIS

McWilliam, S. J., Antoine, D. J., Rosala-Hallas, A., Jones, A., MacLean, C., Prayle, A., . . . Pirmohamed, M. (2017). THE PROTEKT STUDY - A PHASE IIA, RANDOMISED, CONTROLLED, OPEN-LABEL TRIAL OF ROSUVASTATIN FOR THE PREVENTION OF AMINOGLYCOSIDE-INDUCED KIDNEY TOXICITY IN CHILDREN WITH CYSTIC FIBROSIS. In PEDIATRIC PULMONOLOGY Vol. 52 (pp. S353). Indiana Convention Center, Indianapolis, Indiana. doi:10.1002/ppul.23840

DOI
10.1002/ppul.23840
Conference Paper

Optimising the use of medicines to reduce acute kidney injury in children and babies

Oni, L., Hawcutt, D. B., Turner, M. A., Beresford, M. W., McWilliam, S., Barton, C., . . . Antoine, D. J. (2017). Optimising the use of medicines to reduce acute kidney injury in children and babies. Pharmacology and Therapeutics, 174, 55-62. doi:10.1016/j.pharmthera.2017.02.018

DOI
10.1016/j.pharmthera.2017.02.018
Journal article

2014

66 Association of urinary kidney injury molecule-1 with aminoglycoside exposure in children with cystic fibrosis

McWilliam, S. J., Antoine, D. J., Smyth, R. L., & Pirmohamed, M. (2014). 66 Association of urinary kidney injury molecule-1 with aminoglycoside exposure in children with cystic fibrosis. Journal of Cystic Fibrosis, 13, S63. doi:10.1016/s1569-1993(14)60202-2

DOI
10.1016/s1569-1993(14)60202-2
Journal article

2012

Mechanism-Based Urinary Biomarkers to Identify the Potential for Aminoglycoside-Induced Nephrotoxicity in Premature Neonates: A Proof-of-Concept Study

McWilliam, S. J., Antoine, D. J., Sabbisetti, V., Turner, M. A., Farragher, T., Bonventre, J. V., . . . Pirmohamed, M. (2012). Mechanism-Based Urinary Biomarkers to Identify the Potential for Aminoglycoside-Induced Nephrotoxicity in Premature Neonates: A Proof-of-Concept Study. PLOS ONE, 7(8). doi:10.1371/journal.pone.0043809

DOI
10.1371/journal.pone.0043809
Journal article

2011

Measurement of the urinary biomarker KIM-1 identifies the potential for aminoglycoside-induced nephrotoxicity in premature neonates

Antoine, D. J., McWilliam, S., Sabbisetti, V., Turner, M., Smyth, R., Pirmohamed, M., . . . Park, B. K. (2011). Measurement of the urinary biomarker KIM-1 identifies the potential for aminoglycoside-induced nephrotoxicity in premature neonates. In TOXICOLOGY Vol. 290 (pp. 107). doi:10.1016/j.tox.2011.09.015

DOI
10.1016/j.tox.2011.09.015
Conference Paper

URINARY KIM-1 AS A BIOMARKER OF AMINOGLYCOSIDE-INDUCED NEPHROTOXICITY IN PREMATURE NEONATES

McWilliam, S. J., Antoine, D. J., Turner, M., Sabbisetti, V., Bonventre, J. V., Park, B. K., . . . Pirmohamed, M. (2011). URINARY KIM-1 AS A BIOMARKER OF AMINOGLYCOSIDE-INDUCED NEPHROTOXICITY IN PREMATURE NEONATES. In PEDIATRIC RESEARCH Vol. 70 (pp. 107). doi:10.1038/pr.2011.332

DOI
10.1038/pr.2011.332
Conference Paper

2010

How to use C reactive protein: postscript

McWilliam, S., & Riordan, A. (2010). How to use C reactive protein: postscript. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 95(6), 194-195. doi:10.1136/adc.2010.196287

DOI
10.1136/adc.2010.196287
Journal article

How to use: C-reactive protein

McWilliam, S., & Riordan, A. (2010). How to use: C-reactive protein. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 95(2), 55-58. doi:10.1136/adc.2009.174367

DOI
10.1136/adc.2009.174367
Journal article

Undated